Storage & Stability

Optimal Storage Conditions

Melanotan 2 is supplied as a lyophilized powder and maintains maximum stability under the following regimen:

• Primary storage: 2–8°C (refrigerated), protected from direct light in amber or opaque vials
• Backup long-term: −20°C (freezer) or −80°C (ultra-low freezer) for extended preservation beyond 12 months
• Shelf life: Approximately 24–36 months when sealed and stored at 2–8°C; reduced to 12–18 months at room temperature
• Reconstitution solvent: Sterile water for injection (WFI), bacteriostatic saline (0.9% sodium chloride with 0.9% benzyl alcohol), or PBS at pH 7.0–7.4

Stability Post-Reconstitution

Once reconstituted, MT-2 solutions degrade progressively. Store reconstituted aliquots at 2–8°C in airtight, sterile containers for a maximum of 14 days. Freezing reconstituted solutions (−20°C) can extend viability to 30–45 days but may result in minor aggregate formation upon thawing. Avoid repeated freeze-thaw cycles.

Tip: Document reconstitution date, solvent type, and concentration on all aliquots. Use sterile technique to prevent microbial contamination and oxidative degradation.

Handling & Aliquoting

Safe Laboratory Protocols

Melanotan 2 handling requires standard precautions for synthetic peptides and research chemicals:

• Personal protective equipment: Lab coat, nitrile gloves, and safety glasses when manipulating powder or solutions
• Work environment: Conduct weighing, dissolution, and aliquoting in a well-ventilated laboratory or biological safety cabinet if particulate inhalation is a concern
• Dust minimization: Avoid generating aerosols during transfers; use enclosed equipment when possible
• Pipetting: Use calibrated, sterile pipettes for accurate dosing in in vitro and in vivo research models

Aliquoting Best Practices

Prepare research-grade aliquots under aseptic conditions. Divide the compound into smaller portions (e.g., 1–5 mg per vial) to minimize exposure during repeated access. Label each aliquot with preparation date, concentration, solvent type, and lot number. Store in sterile, sealed containers at appropriate temperatures. Use dedicated freezers with temperature monitoring and backup power supply.

Tip: Prepare aliquots immediately after receipt to reduce handling frequency and preserve potency. If microbial contamination is suspected in any vial, isolate and discard it to protect the integrity of remaining stock.

Documentation Checklist

Comprehensive record-keeping supports regulatory compliance and reproducibility. Maintain the following documentation:

Note: Regulatory agencies (FDA, EMA) increasingly scrutinize compound sourcing and handling records. Comprehensive documentation demonstrates due diligence and supports any inquiries into research integrity.

Example Non-Clinical Models

In Vitro Melanocyte Culture

Melanotan 2 is commonly studied in cultured human melanocytes and murine B16 melanoma cells. MT-2 activates melanocortin 1 receptor (MC1R) signaling, triggering cAMP elevation and MITF (microphthalmia-associated transcription factor) upregulation. Researchers typically measure melanin content via spectrophotometry, quantify tyrosinase activity, and assess gene expression (TYR, TYRP1, MITP1) using qPCR. Dose-response studies often employ MT-2 concentrations ranging from 10−9 to 10−6 M to establish potency curves.

In Vivo Pigmentation Studies

Animal model applications have included transgenic mice, Xenopus tadpoles, and zebrafish larvae to investigate melanocortin signaling in vivo. Research typically measures skin darkening (reflectance spectroscopy or digital image analysis), histological melanin deposition, and hair color changes in mammalian models. Studies examining aging-related pigmentation and photo-protective mechanisms have been conducted in rodent models under IACUC oversight.

Receptor Binding & Selectivity

Binding affinity studies employ recombinant melanocortin receptor subtypes (MC1R through MC5R) expressed in HEK293 or CHO cells. Competition radioligand assays ([125I]-NDP-MSH) or fluorescence-based high-throughput screening characterize MT-2 affinity and selectivity. Literature reports indicate MC1R Ki values in the nanomolar range, with cross-reactivity at MC3R and MC4R at higher concentrations.

Note: All animal studies must obtain prior institutional approval (IACUC) and comply with animal welfare regulations (Guide for the Care and Use of Laboratory Animals, AVMA Guidelines).

Compliance & Risk Notes

Regulatory Classification

Melanotan 2 is classified as a research chemical and is not approved for human therapeutic use in the United States, European Union, or most other jurisdictions. It is explicitly prohibited for human consumption, veterinary use, or any application outside of qualified institutional research. Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, marketing MT-2 as a dietary supplement or health product is illegal. The FDA and equivalent regulatory bodies in other nations have issued warnings against unauthorized distribution and use of MT-2.

Risk Mitigation

Organizations using MT-2 must maintain compliance protocols: obtain institutional approval (IACUC for animal studies, IRB for human-subjects research if applicable), restrict access to qualified scientific personnel, maintain secure storage, implement destruction procedures for unused material, and maintain comprehensive audit trails. Researchers must assume that any use inconsistent with approved laboratory research protocols may constitute violations of controlled substance or pharmaceutical regulations.

Third-Party Verification

Upon receipt, verify product identity and purity via certificate of analysis. Recommended validation methods include high-performance liquid chromatography (HPLC), mass spectrometry (LC-MS or MALDI-TOF), and amino acid analysis. Cross-reference supplier documentation against peer-reviewed characterization data to ensure material authenticity and research-grade quality.

Disclaimer: This document is provided solely for regulatory and institutional compliance reference. Organizations bear full responsibility for ensuring all use conforms to local, state, and federal law. Unauthorized distribution, possession, or use of MT-2 for any non-research purpose may violate criminal statutes.

References & Evidence Snapshot

Peer-Reviewed Literature

• Grieco P, et al. J Med Chem. 2000;43(24):4650-4656. Cyclic α-MSH analogues (including MT-2): receptor binding and melanogenesis.
• Dorr RT, et al. Life Sci. 1996;58(15):1427-1436. Melanocortin agonists and pigmentation control in murine models.
• Catania A, et al. Pharmacol Rev. 2004;56(1):1-29. Melanocortins: multiple actions and physiological roles.
• Ringholm A, et al. Pigment Cell Melanoma Res. 2004;17(3):242-254. Human melanocortin 1 receptor (MC1R) genetic variation and phenotype correlation.
• Chagnon YC, et al. Obes Rev. 2003;4(3):159-168. Melanocortin pathway mutations in obesity and metabolic disease.

Mechanistic Summary

Melanotan 2 functions as a non-selective melanocortin receptor agonist with highest affinity for MC1R. Binding initiates Gs-coupled activation of adenylyl cyclase, elevating intracellular cAMP. Downstream signaling involves PKA activation and phosphorylation of CREB, leading to MITF expression and transcription of melanogenic enzymes (tyrosinase, TYRP1, DCT). The compound exhibits rapid onset and offset of action in vitro; in vivo effects depend on route of administration, tissue distribution, and receptor density in target tissues.

Quality Assurance Metrics

Research-grade MT-2 typically reports ≥95% purity by HPLC. Amino acid analysis confirms the expected sequence. Water content by Karl Fischer titration should be <5% for lyophilized material. Bacterial endotoxin (LAL assay) should be <1 EU/mg. Microbial limits testing (plate counts, gram-negative organisms) must meet USP <61> and <62> standards for research-grade materials.